CIBC Private Wealth Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

CIBC Private Wealth Group’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$162K	Buy	2,901 +95	+3%	+$4.92K	﹤0.01%	1291
2025 Q3	$135K	Buy	2,806 +26	+0.9%	+$1.16K	﹤0.01%	1358
2025 Q2	$113K	Hold	2,780	–	–	﹤0.01%	1335
2025 Q1	$102K	Hold	2,780	–	–	﹤0.01%	1343
2024 Q4	$119K	Hold	2,780	–	–	﹤0.01%	1353
2024 Q3	$123K	Hold	2,780	–	–	﹤0.01%	1392
2024 Q2	$110K	Hold	2,780	–	–	﹤0.01%	1366
2024 Q1	$119K	Buy	+2,780	New	+$120K	﹤0.01%	1321

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

CIBC Private Wealth Group's XPH Position: Q4 2025 in Review

CIBC Private Wealth Group increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 3.4% in Q4 2025, buying an estimated $4.92K and bringing the position to 2,901 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

CIBC Private Wealth Group first reported a position in XPH in Q1 2024 and has held it in 8 quarters since. 78 funds tracked by Wall St. Rank hold XPH as of Q4 2025.

CIBC Private Wealth Group held 2,901 shares of State Street SPDR S&P Pharmaceuticals ETF worth $162K as of Q4 2025.
CIBC Private Wealth Group bought 95 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2025, an estimated $4.92K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1291 holding.
CIBC Private Wealth Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2024 and has held it in 8 quarters since.
78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.